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Abstract.  
Microtubules assembled with paclitaxel and docetaxel differ in the 
number of protofilaments, reflecting modification of the lateral association 
between -tubulin molecules in the microtubule wall. These modifications of 
microtubule structure, through a non-yet characterized mechanism, are most 
likely related to the changes in tubulin-tubulin interactions responsible for 
microtubule stabilization by these antitumor compounds. We have used a set 
of modified taxanes to study the structural mechanism of microtubule 
stabilization by these ligands. 
 Using Small Angle X-ray Scattering, we have determined how 
modifications in the shape and size of the taxane substituents result in 
changes in the interprotofilament angles and in their number. The observed 
effects have been explained using NMR-aided docking and molecular 
dynamic simulations of taxane binding at the microtubule pore and luminal 
sites. Modeling results indicate that modification of the size of substituents at 
positions C7 and C10 of the taxane core influence the conformation of three 
key elements in microtubule lateral interactions (M-loop, S3 beta strand and 
H3 helix) that modulate the contacts between adjacent protofilaments. 
Whereas, modifications of the substituents at position C2 slightly rearrange 
the ligand in the binding site, modifying the interaction of the C7 substituent 
with the M-loop. 
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Introduction. 
 Fully assembled microtubules are long hollow cylinders of 
approximately 25 nm diameter composed of laterally associated tubulin 
protofilaments. The number of protofilaments per microtubule, can range from 
10 to 18, although the number is usually 13 in vivo. In contrast, this number is 
variable in vitro and depends on the experimental conditions. It should be 
stressed that the actual protofilament number is heterogeneous and follows a 
distribution. In fact, the number of protofilaments is given as an average figure 
(1). 
Taxanes are a class of anti-tumor drugs in clinical use (2), which exert 
their cytotoxic action through the microtubule cytoskeleton. Paclitaxel (Figure 
1) and its chemical relatives, such as docetaxel, belong to this group of drugs 
(3). Taxanes prevent microtubule disassembly by activation of GDP-bound 
tubulin (4-5). They were the first available class of compounds with 
microtubule-stabilizing agent (MSA) activity. 
Several models have been proposed (see (6) for a review) to explain 
the structural mechanisms of microtubule assembly, the most simplistic one 
proposes the one by one addition of tubulin dimers to the growing end of a 
nucleus (7). In our case, MSA-induced microtubule assembly, the structural 
pathway of MSA-induced microtubule assembly has been studied using Small 
Angle X-ray Scattering (SAXS), (8). Under the biochemical conditions of this 
study, and in the presence of MSA, the first structural step of the assembly 
involves oligomerization of tubulin dimers in the presence of Mg+2 ions, in a 
head to tail way, to form linear oligomers, called protofilaments. These linear 
oligomers laterally associate to form the nucleus, (this process is mediated by 
the MSA) which grows until the number of protofilaments are sufficient to 
display cylindrical morphology, with the correct interprotofilament angle 
(Figure 1). This so-called ‘Interprotofilament angle’ is defined as the average 
angle between protofilaments in the cylindrical cross section (see inset in 
Figure 2A). The nucleus then elongates by incorporating new tubulin subunits 
to the growing end of the cylinder. This model is compatible with previous 
observations of intermediate sheet structures (9) and with the observed fast 
growth of existing microtubules from elongation of sheet-like structures at the 
growing ends (10). However, we should point out that although the MSA-
induced microtubule assembly, which we are studying in this paper, can be 
considered as model system of the physiological GTP-induced microtubule 
assembly, the exact mechanism of GTP-induced tubulin assembly both in vivo 
and in vitro is controversial (11-12) and thus microtubule formation may 
proceed through a different structural pathway. 
In earlier studies on the interaction of taxanes with microtubules we 
found that the structure of paclitaxel-induced microtubules is different from the 
structure of those assembled in the absence of this drug (13). In the presence 
of paclitaxel, microtubules assembled with an average of 12.1 protofilaments 
(13), which is rather different to the average number of protofilaments found in 
vitro (13.4). Strikingly, when assembled in the presence of docetaxel, the 
microtubules have an identical average protofilament number to that found in 
the absence of drugs (14). The most straightforward explanation for this 
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observation would be that these compounds can alter the way in which 
protofilaments interact laterally. In addition, the exchange of paclitaxel for 
docetaxel, or the addition of Flutax-2 (a chemically modified fluorescent 
analogue) to microtubules preassembled in the absence of drugs resulted in 
rapid changes (within a time scale of less than 1 minute) in the number of 
protofilaments (8,15-16). Therefore, the mechanism of MSA-induced 
assembly should modify the interprotofilament angle and subsequently the 
average number of microtubule protofilaments. 
Although high resolution electron diffraction located the main paclitaxel 
binding site on the internal surface of microtubules (17), rather remote from 
the interprotofilament space, our studies (18-21) have provided evidence of 
the existence another binding site for MSAs. This site is on the vicinity of 
residue T220 of -tubulin (at the outer surface of the pore in the microtubule 
wall). On the other hand, it has been described that binding of paclitaxel to the 
luminal site of microtubules facilitates the interaction between the S7-H9 loop 
(M-loop) of -tubulin and H1-S2 loop of the adjacent subunit (17). This 
enhanced M-loop H1-S2-loop interaction has been proposed as one of the 
key reasons for the microtubule-stabilizing activity of paclitaxel (22). In both 
cases, (binding in the outer surface of the pore or at the luminal site), MSA-
tubulin interactions take place close to the interprotofilament region, so it is 
not unreasonable to imagine that they should modify the corresponding angle 
and thus, the microtubule structure. 
Herein, we have employed SAXS to determine the average 
microtubule diameter and the number of protofilaments. By comparing SAXS 
data of microtubules assembled in the presence of a series of different 
modified taxanes (Figure 1) it has been possible to shed light on the 
mechanisms involved in the modification of the microtubule structure by these 
ligands. On this basis, the goal of this work has been to obtain insights, at 
molecular and atomic resolution, into the mechanisms of MSA-induced 
microtubule assembly by understanding how ligands with different chemical 
functional groups may modify the interactions between protofilaments. These 
events are probably related to those which modulate tubulin-tubulin 
interactions and induce microtubule assembly. Therefore, taxane derivatives 
with different sizes and shapes have been selected from a library of active 
compounds (23). In particular, a number of molecules have been selected for 
our study according to different observations; since the first differences in the 
observed number of protofilaments involved paclitaxel and docetaxel, which 
mainly differ in the substitutions at the C13 lateral chain (at the “eastern” part 
of the molecule), these two molecules and related analogues have been 
initially selected for our study. However, between these two key molecules 
there is also one smaller modification at position 10 (in the “north” part of the 
taxane core), which was also chosen for further exploration. On the other 
hand, we also decided to explore the consequences of the chemical 
differences between paclitaxel, Flutax-1 and Flutax-2, which involve the C7 
lateral chain (at the “north-east” part of the taxane core). Additionally, the 
effect of modifications at the C2 side chain (in the “southern” part) has also 
been evaluated, since they have a significant influence on the binding of 
taxanes to microtubules (23). 
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Materials and Methods 
Ligands and protein. 
Purified calf brain tubulin and chemicals were purified, synthesized and 
used as described (5,16,18,23-24). Baccatin III was from Sigma-Aldrich (St. 
Louis, USA). All compounds were dissolved at 50 mM concentration in D6-
DMSO. 
X-ray scattering measurements. 
 Tubulin was equilibrated in 10 mM sodium phosphate, 1 mM EDTA, 0.1 
mM GTP, buffer pH 7.0 through a Sephadex G-25 medium column (25x9 
mm), and the protein was centrifuged for 20 min at 90.000xg in a TLA120.2 
rotor in a Optima TLX centrifuge (Beckman) to remove aggregates. The 
tubulin concentration was then determined spectrophotometrically as 
described (25). MgCl2 (7 mM) and up to 1 mM GTP were added to the sample 
(final pH 6.7) and the desired ligand or DMSO (vehicle) in a 10% 
stoichiometric excess over the protein concentration was added, and the 
samples were incubated for 20 minutes at 37ºC and kept at 25ºC before 
recording the scattering patterns. 
SAXS data collection was performed either at BM26B station 
(DUBBLE) of the ESRF in Grenoble (France) or at a Bruker NANOSTAR 
system (see Supplementary information for details).  
The low angle X-ray scattering pattern of microtubules in solution can 
be described as the Fourier transform of a hollow cylinder. To a first 
approximation, the intensity is given by the zero’th order Bessel function 
, q being the scattering angle and R, the cylinder radius (26). The 
position of the first scattering maximum is therefore a sensitive measure for 
the radius of the microtubule, via the relation J01=(1.22/2R) since in a solution 
scattering pattern these are not distorted due to overlap between the higher 
order diffraction maxima of the helical lattice (13-14).
 
The differences in diameter between microtubules assembled in the 
presence of different taxanes can be interpreted, to a good approximation, as 
changes in the average number of protofilaments making up the cylinder wall. 
NMR sample preparation and experiments 
The samples of the ligands bound to microtubules were prepared, 
measured at 310 K in D2O on Bruker AVANCE 500 MHz or 700 MHz 
spectrometers and analized as described (21). Off-rate constants between 1-
200000 s-1 were tested in order to fit the experimental STD effects and TR-
NOE intensities. Optimal agreement was achieved for koff = 90 s-1 for 
cephalomanine, Chitax-1, Chitax-4 and Chitax-17 and for 110 s-1 for Flutax-2. 
Docking and molecular dynamics calculations.  
Docking of the ligands was performed as described (21) (see 
  20J qR
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Supplementary information for details). 
Autodock poses with the best fitting between experimental and 
calculated STD values were refined by using molecular dynamic simulations 
(MD) performed with AMBER 9 (27), (500 ps equilibration time, 2 ns 
acquisition time). For each compound 100 structures were saved along the 
last ns of the MD trajectory. The predicted STD values of each structure were 
obtained with CORCEMA-ST and the average STD values of these 100 
structures were considered for comparison against the experimental data. 
Finally, the Normalized Root-Mean-Square Deviation (NRMSD) between 
these average STD values and the experimental STD were calculated for 
each proton of the ligand. 
The volume of the Solvent Excluded Surface (V-SES) by the side 
chains of the taxanes was calculated using the MSMS procedure (28) to 
calculate the excluded surface and the Chimera program (29) to calculate the 
volume under the excluded surface.  
 
Results 
SAXS determination of the sizes of the ligand induced microtubules 
Tubulin assembly was induced in the presence of the different ligands 
and the corresponding SAXS profiles were recorded for each microtubule 
population. Figure 2 shows the comparison of the profiles for selected 
molecules differing in a single position of the taxane side chain. From these 
profiles, the positions of the first order Bessel function maxima J01 were 
determined and appropriate controls were performed to assure that the 
position of Jn peak (proportional to the distance between the center of the 
protofilaments) remained constant in all cases. From these data the average 
microtubule diameters and average protofilament number were calculated 
(Table I).  
Except for the case of Chitax-14 in which the valleys are remarkably 
less pronounced, indicating a larger proportion of open microtubular sheets 
(8), the width of the peaks and the ratio between the maximum of the J01 peak 
and the minimum between J01 and J02 is very similar for all the compounds 
studied.  This indicates that the distribution of protofilament numbers and the 
proportion of open microtubular sheets should be similar for all ligand induced 
microtubules and also similar to these previously described by electron 
microscopy (1,8,13-14). 
Effect of the modification of the ligand size, at selected positions, in the 
microtubule structure.  
The effects of single point changes of the taxane molecule, on the 
interprotofilament contacts can be then calculated from the changes in the 
number of protofilaments (Table II). When the SAXS patterns of paclitaxel-
induced microtubules (Figure 2A, green line) are compared with patterns of 
 7 
 
microtubules assembled in the presence of Chitax-21 and cephalomannine 
(paclitaxel equivalents with specific modifications only at the C13 side chain) 
the differences in the position of the J01 maxima fell within the experimental 
error (Table II) (Figure 2A, black and red lines, respectively). The same result 
was obtained for the rest of the taxanes with single point modifications at C13 
side chain (Table II). Only the removal of the C13 side chain (from paclitaxel 
to baccatin III) resulted in a large decrease of 1.7 units in the average number 
of protofilaments. 
 The result indicates that the change in microtubule structure observed 
between paclitaxel-induced and docetaxel-induced microtubules (13-14) was 
actually not due to the modification at the side chain. However the results 
point towards a strong influence of the volume of the side chain in the 
interaction with the binding site. In fact the size of the two side chains involved 
(phenyl for tert-butyl) is nearly the same as it is shown by the calculation of 
the change in the volume of the Solvent Excluded Surface (V-SES) by the 
side chain (Table II) (-11 Å3). Exchange of these two side chains for a 
different one with a similar size (butylen) (phenyl for butylen +15 Å3) does not 
result in an appreciable change in the protofilament number while removing of 
the side chain which results in a volume change of -256 Å3 results in a large 
decrease of the average number of protofilaments. 
 It is therefore evident that the difference observed between the 
structure of the microtubules induced by paclitaxel and those induced by 
docetaxel should arise from the difference of the group at position 10 (acetyl 
group vs. a free OH moiety, for paclitaxel and docetaxel respectively), and 
corresponds to a volume decrease of 42 Å3 
An increase of volume of the position 10 resulted in a small but 
consistent decrease in the number of protofilaments of the induced 
microtubules. The introduction of acetyl (cephalomannine, red line, Figure 2B) 
or propionyl (+53 Å3) groups (Chitax-18, black line, Figure 2B) at position 10 
resulted in a decrease of the microtubule diameter as compared with Chitax-
17 (green line, Figure 2B) (Table II). When an acetyl group was introduced as 
a single point modification at position 10, the average decrease in the number 
of protofilaments was 0.7. When a propionyl group was introduced, the 
decrease corresponded to 1.0 protofilaments.  
 An opposite effect is seen for the other group in the north face of the 
molecule, C7 also pointing towards the interprotofilament space in both 
binding sites. The introduction of bulky groups instead of the free hydroxyl, 
such as fluorescein (+366 Å3) and difluorofluorescein (+375 Å3) (Flutax-1 and 
Flutax-2), at this position resulted in a large increase in the microtubule 
diameter (16). However, the relatively large size of these groups may result in 
additional interactions. Therefore a further experiment comparison was also 
performed for analogues bearing a smaller propionyl side chain (+53 Å3). 
Thus, the effect observed could be compared to that monitored for the 
equivalent change at position 10.  
 The introduction of a propionyl side chain at C7 (Chitax-17->Chitax-1) 
resulted in an increase in the diameter of the microtubules (Figure 2C, green 
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line for Chitax-17 and black line for Chitax-1), equivalent to 1.4 extra 
protofilaments. Accordingly, this variation was similar to that observed for the 
introduction of the fluorescein moieties mentioned above, with 1.6 extra 
protofilaments (see Table II). Interestingly, the introduction of a bulkier group, 
as in 7-hexaflutax (+453 Å3), resulted in the largest change in diameter 
observed, corresponding to 2.1 protofilaments, as also shown in Table II. 
 Since the “south face” of the molecule and, more precisely, the benzyl 
moiety at C2 position of the taxane ring strongly influences the interactions of 
these compounds with the luminal site (23) and, very probably, also with the 
pore site, (20) we have studied the modifications at C2 that highly modulate 
the binding affinity. In both cases, the C2-modified molecules with groups at 
the meta position of the ring, which increase the binding affinity, amplified the 
microtubule diameter (Table II). An average increase of 0.7 units was 
observed for compounds bearing an azide substituent, which added extra 35 
Å3 (-N3, Chitax-14, black line in Figure 2D) and an average increase of 0.8 
units for the methoxy-containing analogues, which added 24 Å3 (-OCH3, 
Chitax-13, green line in Figure 2D). 
NMR and molecular modeling. 
Three-dimensional models of the ligands bound to the two alternative 
binding sites (the luminal and the pore site) were obtained in order to 
understand the effects, at the structural level, of ligand binding to 
microtubules. A combined NMR and modeling approach was employed when 
NMR experiments could be performed. Unfortunately, taxane solubility 
problems precluded the general use of the combined procedure. However, in 
the case of docetaxel (21),(23), paclitaxel, chitax-42 and flutax-2 (this work), 
NMR-based information could be obtained regarding the bioactive 
conformations and the binding epitopes of the ligands, which was employed 
as a guide for the modeling procedures.  
STD experiments detect magnetization transfer from the protein to a 
bound ligand. Only bound ligands show STD signals and, as in any NOE-type 
experiment, the STD effect observed depends on the distance between the 
protons of the protein and those of the ligand, thus providing a useful tool to 
detect the ligand epitope and to structurally probe the binding site. This 
information is of paramount importance to improve the docking models. 
However, there are kinetic requirements for these experiments to be 
successful. Indeed, STD and TR-NOESY (Transferred NOE effect) 
experiments, (which permits deducing the bioactive conformation of the 
ligand) require a fast off-rate in the relaxation time scale. Therefore, as 
previously discussed, the characteristic slow dissociation of the ligands from 
the luminal site in the microtubules precludes the observation of TR-NOESY 
and STD signals from the ligand when bound to this site (23). As a matter of 
fact, the calculated STD-profiles of the taxanes bound to the luminal site 
cannot reproduce those experimentally determined (21). Thus, the NMR-
based information for these systems can only be employed to model the pore-
bound poses. 
Three model compounds were selected for the construction of the 
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model “average” STD profile of taxanes. Paclitaxel and docetaxel were 
selected as lead compounds in the series, while Chitax-42 (a low affinity 
compound with a modified linker at C2) was chosen to determine if all active 
taxanes bind to microtubules in the same way. Flutax-2 (16) was also 
measured as an example of those analogues bearing bulky probes at C7.  
STD and TR-NOESY data were acquired for paclitaxel, Chitax-42 and Flutax-
2 (experimental data are shown in Figure 3A, a higher resolution version of 
the TR-NOESY spectra is available as supplemental information (Figure S1)). 
Docetaxel data was taken from our previous studies (21,23). Regarding the 
taxane part of the molecules, the molecular conformation deduced from TR-
NOESY spectra was, found to be identical to that previously described for 
docetaxel (21,23).  
Flutax-2 was modeled in the pore site (Figure 3B), employing its 
experimentally measured STD profile (Figure 3C), as described in Materials 
and Methods. The normalized root mean square deviation factor (NRMSD) of 
the best model was 19.38%, in between those obtained for the previously 
published models of docetaxel 9.9% and discodermolide 22.4 % bound to 
microtubules (21). Given the bulky group at C7 which may be involved in 
additional interactions with the binding site, STD effects of Flutax-2 protons 
were not employed to build the model “averaged” STD profile for the common 
protons of paclitaxel, which was later use to model the non-fluorescent 
ligands. 
 Four selected ligands (cephalomanine, Chitax-1, Chitax-4 and Chitax-
17, which differ in single points at C7 (Chitax-17 and cephalomannine), C10 
(Chitax-17 and Chitax-1) and C2 (Chitax-1 and Chitax-4)), were modeled in 
the pore site employing the model “average” STD profile of taxanes. These 
ligands were chosen because of their possible influence on the microtubule 
interprotofilament contacts described above. As in the case of Flutax-2, the 
compounds were first docked into the pore site, and produced different poses. 
Following this procedure, the geometries of the docking poses were employed 
to calculate the expected STD profiles (30). The poses were then classified by 
comparing their expected STD values to those of the model “average” taxane 
(Figure 3D), and their geometries were compared to those experimentally 
determined for docetaxel (23), and to those estimated for the T-Taxol 
conformation (31). Based on the conservation of the TR-NOESY profile, only 
those models in which the structure of the ligand was compatible with either of 
these geometries were further considered (Table S1). NRMSD between the 
STD estimations was considered to quantify the similarities, as described in 
the experimental section. The NRMSD values obtained (Cephalomannine 
18.93%, Chitax-1 18,26%, Chitax-17 16,23 %, Chitax-4 18,79%) and the 
models were in between those determined for the best structures previously 
obtained for docetaxel and discodermolide (21) (Figures 4A-C). The ligands 
were found to bind between the tubulin -subunit, close to the luminal site (1, 
following the Magnani nomenclature (32)), and the -subunit of the next dimer 
in the protofilament (2, see Figure 5A of (21), cyan structure), as previously 
described for docetaxel (21). However, although the location of the binding 
site was similar to that described by Magnani (but rather different to that found 
by Freedman et al.(33), close to subunits 1 and 4), the binding pose of the 
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ligands was rather different to that described by Magnani (32). 
 Alternatively, the four ligands were modeled in the luminal binding site 
(1JFF model) (17) by direct docking of the geometries constructed from the 
TR-NOESY-determined docetaxel conformation (23), as previously described 
(34) (Figures 4E-H). 
The geometries of the “best” docking poses were considered as initial 
structures for MD simulations. In this way, the influence of the different ligands 
on the interprotofilament contacts were evaluated. As hypothesized, the 
different chemical moieties at the peripheral substitutions made distinct and 
specific contacts with determined protein regions. Local perturbation of the 
conformations of the H3 and S3 elements of the -tubulin subunit at the right 
side of the pore (orange subunit) was observed when the ligand was bound to 
the pore site (Figures 4A-C). Alternatively, perturbations in the topology of the 
-tubulin M-loop, which contains the luminal site, were detected when the 
ligand was bound to this site (Figures 4E-H). These changes on the protein 
conformation are likely to result in variations of the interprotofilament contacts.  
Figure S2 shows the effect of the cephalomannine, Chitax-17, Chitax-
1, and Chitax-4 series in the M-loop. They induced 12.6, 13.4, 14.8, and 15.2 
protofilament-containing microtubules, respectively. It could be deduced that 
these molecules, especially cephalomannine and Chitax-17, induced the 
closing of the M-loop towards the luminal site, thus giving rise to the formation 
of microtubules with a low number of protofilaments. 
 
Discussion 
In order to better understand the mechanism of MSA-induced 
microtubule assembly and why interprotofilament contacts and subsequently 
the microtubule structure are altered as compared with GTP-induced 
assembly, different taxanes with groups of different sizes at selected positions 
were employed. We then observed how the modification in the taxane shape 
is reflected in the microtubule structure, assuming that it is unlikely that the 
general features of the interaction of the ligand with the binding sites would be 
altered by these minor modifications. NMR-directed models of the formed 
complexes have been constructed in order to understand, at high resolution, 
how the different taxanes modify microtubule structure, and cause 
stabilization. In this way we have constructed a data-directed model of the 
interaction of taxanes with both the pore and the luminal site of microtubules, 
and of the conformational effects that binding to these sites produce in 
contacting tubulin subunits. Thus, the SAXS data, and the observed 
modifications in the number of protofilaments, can be discussed in terms of 
the NMR-directed docking models obtained. 
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How does ligand binding to the pore and luminal sites affect microtubule 
structure 
In order to properly understand the effects of the changes in the ligand 
side chains on the interprotofilament structure, we have carefully examined 
the models of the complexes of the ligands with both binding sites. Our initial 
working hypothesis was that the interaction of the different taxane ligands with 
the pore binding site (19,35), located between the protofilaments, should be 
the one most likely involved in the modifications observed in the 
interprotofilament angle and thus the average number of protofilaments out of 
which the microtubule cylindrical structure is composed. In agreement with 
this hypothesis, the only compound which is known to bind exclusively to the 
microtubule pore, 7-hexaflutax (18,20), is the ligand that produces the largest 
effect on the microtubule structure.  
Given the transient nature of the interaction of all taxanes except 
Hexaflutax with the pore site, it is only possible to determine the ratio of 
compound bound to each of the sites for the fluorescent compounds Flutax-1 
(10% outer site) and Flutax-2 (1% outer site) (16). However, for docetaxel, 
STD and TR-NOESY NMR analysis of the ligand-receptor systems also 
indicates that a significant percentage of non-fluorescent taxanes would have 
to be bound to the pore site (23). 
However, the strong difference between the ratios of binding of these 
three compounds Flutax-1, Flutax-2 and Hexaflutax to both sites as compared 
with the similarity of sizes of the groups (366, 375 and 453 Å3) and the 
microtubules induced by these drugs (14.6, 14.6 and 15.1 pf) suggests that 
either the effect is exerted through both the luminal and the pore sites or that 
only a small proportion of the ligand is enough to produce the effect on 
microtubule structure. Thus, in order to gain information about the specific 
effect, both models of the interaction with the pore and with the luminal site 
have to be analyzed. 
The results indicate that the main effect of ligands at both the pore site 
and the luminal site is due to the modification of the size of groups at positions 
C7 and C10. The analysis of the 3D models of the ligands derived from NMR 
and docking simulations with O-substituents at the "North face" of the 
molecule (taxane positions C7 and C10) reveals a well defined interaction 
mode with the pore site. The groups at these positions strongly interact with 
the secondary H3 and S3 structure elements of the -tubulin subunit at the 
adjacent protofilament modifying their molecular conformations (Figure 4D 
and Figure S2A), while the positions which are relevant to the binding, C2 and 
C13, are oriented towards the center of the protofilament (Figure 4). When no 
substituents are present at the hydroxyl groups at C7 and C10, the groups are 
exposed to the solvent making favorable interactions with the water 
molecules, and in turn does not interact with the protein (accordingly, 
compounds with no substituents at the hydroxyl groups at C7 and C10, such 
as docetaxel, Chitax-15, and Chitax-17, have little influence on the 
microtubule diameter). Fittingly, when a hydrophobic group is present at this 
location, the protein rearranges its conformation to protect the non polar areas 
from the solvent. When the substitution takes place at C7, which is close to 
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the surface of the pore, the H3 helix changes its topology, resulting in a more 
compact conformation the bigger the side chain is. This in turn, results in 
protofilament-protofilament interactions with larger interprotofilament angles. 
Alternatively, for the C10-substituted analogues, the modified position is 
closer to the inner surface. In this case, the tubulin S3 strand rearranges to 
close the interprotofilament contacts in the inner part of the protein. This 
process involves a reduction in the interprotofilament angle, and thus thinner 
microtubules, with less protofilaments, are formed. The effect on the pore 
structure can be clearly seen in Figure 4. In the presence of cephalomannine 
(Figure 4A), which contains an acetyl group at position 10 and a hydroxyl at 
position 7, the H3 helix is not well structured (magenta) and is located far from 
the ligand. In contrast, when the C10 acetyl is removed and a propionyl group 
is introduced at C7 (Chitax-1, Figure 4B), the helix becomes stable and 
interacts with the ligand. A similar effect can be observed with Flutax-2 
(Figure 4C). 
The modeling indicates that when the ligands are bound to the luminal 
site, the influence of the ligands is exerted through changes in the orientation 
of the tubulin M-loop (see Figures 4D-G and Figure S2B). A similar effect has 
been observed by Mitra and Sept (36) in a large scale molecular simulation, 
employing the T-taxol conformation (37). This indicates that, as previously 
proposed, the effect on this loop is one of the reasons for the microtubule 
stabilizing effect. Substitutions at taxane positions C7 and C10 produce 
different orientations of this secondary tubulin structure element. There are 
different structures of the M-loop (Figure S2B) when an acyl substituent is at 
position 10, as in cephalomannine (yellow loop), or when a large substituent is 
located at position 7, as in Chitax-1 (green loop). Interestingly, for non-
substituted hydroxyl groups at C7 and C10 (as in Chitax-17), the M-loop 
adopts the intermediate orientation (white loop) between those described 
above. Looking at the structural basis for the observed variations, the 
presence of the acyl substituent at position 10 induces changes in the 
orientation of the M-loop, which shifts inwards due to contacts between the 
acyl moiety with Arg278 and Thr276. These interactions result in the 
existence of closer contacts between protofilaments in the luminal part of the 
microtubule wall and therefore in smaller interprotofilament angles. 
Microtubules assembled in the presence of Chitax-17 resulted in a 
microtubule cylinder with an average of 13.4 protofilaments, while 
cephalomannine-microtubules only contained 12.6. In contrast, the presence 
of substituents at taxane position 7 induced the outward shifting of the M-loop, 
due to contacts between the acyl group and Gln282. This alternative shift 
results in the assembly of microtubules with larger interprotofilament angles. 
In fact, Chitax-17 microtubules have 13.4 protofilaments, while Chitax-1 
microtubules have 14.8. 
The models of the ligands docked both into the pore and into the 
luminal binding site (Figure 4) indicate that the C13 side chain is not 
interacting with the loops responsible for the interprotofilamet contacts. Thus, 
the large change observed in its absence should be the result of a different 
pose of baccatin III in the sites, further away from the S3 and H3 loops in the 
pore site and from the M-loop in the luminal site.  
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The increase in volume of the meta group of the benzyl moiety at 
taxane position C2 produced alternative variations at other locations in the 
luminal binding pocket. As a key example, incorporation of an azide moiety at 
the C2 aromatic ring resulted in a closer interaction of the ligand with His229, 
which has been proposed as the main reason for the observed increase in 
affinity (23). This intermolecular interaction slightly modified the presentation 
of the ligand and forced a large movement of the M-loop towards the 
interprotofilament space (Figure S2B, blue loop). This motion produced the 
concomitant change in the number of protofilaments, which increases from 
14.8 for Chitax-1 to 15.2, for Chitax-4. This effect can also be easily observed 
by inspecting Figure 4. In the presence of just a hydroxyl group (as for Chitax-
17, Figure 4H), the M-loop packs closer to the ligand than in the presence of 
an acetyl group at position 7 (Chitax-1, Figure 4F). This effect is reinforced 
with the addition of the N3 moiety to the aromatic ring at C2 (as for Chitax-4, 
figure 4G). 
 
Conclusions 
The mechanisms of ligand induced microtubule stabilization have been 
explored with a set of taxane analogs. These ligands modify the structure of 
these polymers by altering the interprotofilament contacts as detected by 
Small Angle X-Ray scattering. Modeling protocols, assisted by NMR 
experiments, have been used for different protein complexes holding ligands 
bound at the pore site or at the luminal site. The modeled 3D structures have 
been employed to analyze the microtubule structural changes detected, 
providing plausible explanations on the structural influence of these 
compounds to modulate microtubule assembly.  
Although it is not strictly possible to isolate the individual effects arising 
from ligand binding to the luminal or to the pore site, simulations indicate that 
the binding process strongly influences the interactions at three tubulin 
regions, with different well-defined secondary-structure elements. These 
regions, the S7-H9 loop (M-loop), helix H3, and the S3 strand (Figure 4D) 
have been described as key elements for interprotofilament interactions (17) 
and could be selectively targeted by employing the adequately designed 
analogues. 
 
Acknowledgments 
We wish to thank Rhône Poulenc Rorer Aventis for supplying the 
docetaxel, Miss. Jessica Field for editing and correcting the text and Matadero 
Municipal Vicente de Lucas de Segovia for providing the calf brains for tubulin 
purification. JRS had a fellowship from “Programa de Cooperación Científica 
entre el Ministerio de Ciencia, Tecnologías y Medio Ambiente de la República 
de Cuba (CITMA) y el CSIC”. This work was supported in part by grants 
BIO2010-16351, BQU2009-08536, MAT2008-03232 from MICINN (to JFD, 
JJB and AN respectively) and NSFC 30930108 to WSF. 
 14 
 
References 
1. Chretien, D., F. Metoz, F. Verde, E. Karsenti, and R. H. Wade. 1992. 
Lattice defects in microtubules: protofilament numbers vary within 
individual microtubules. J Cell Biol 117:1031-1040. 
2. Montero, A., F. Fossella, G. Hortobagyi, and V. Valero. 2005. 
Docetaxel for treatment of solid tumours: a systematic review of clinical 
data. Lancet Oncol 6:229-239. 
3. Buey, R. M., I. Barasoain, E. Jackson, A. Meyer, P. Giannakakou, I. 
Paterson, S. Mooberry, J. M. Andreu, and J. F. Díaz. 2005. Microtubule 
interactions with chemically diverse stabilizing agents: 
Thermodynamics of binding to the paclitaxel site predicts cytotoxicity. 
Chem Biol 12:1269-1279. 
4. Schiff, P. B., and S. B. Horwitz. 1981. Taxol assembles tubulin in the 
absence of exogenous guanosine 5'-triphosphate or microtubule-
associated proteins. Biochemistry 20:3247-3252. 
5. Díaz, J. F., and J. M. Andreu. 1993. Assembly of purified GDP-tubulin 
into microtubules induced by taxol and taxotere: reversibility, ligand 
stoichiometry, and competition. Biochemistry 32:2747-2755. 
6. Wu, Z., H.-W. Wang, W. Mu, Z. Ouyang, E. Nogales, and J. Xing. 
2009. Simulations of Tubulin Sheet Polymers as Possible Structural 
Intermediates in Microtubule Assembly. PLoS One 4:e7291. 
7. VanBuren, V., L. Cassimeris, and D. J. Odde. 2005. Mechanochemical 
model of microtubule structure and self-assembly kinetics. Biophys J 
89:2911-2926. 
8. Díaz, J. F., J. M. Andreu, G. Diakun, E. Towns-Andrews, and J. 
Bordas. 1996. Structural intermediates in the assembly of taxoid-
induced microtubules and GDP-tubulin double rings: time-resolved X-
ray scattering. Biophys J 70:2408-2420. 
9. Erickson, H. P. 1974. Microtubule surface lattice and subunit structure 
and observations on reassembly. J Cell Biol 60:153-167. 
10. Chretien, D., S. D. Fuller, and E. Karsenti. 1995. Structure of growing 
microtubule ends: two-dimensional sheets close into tubes at variable 
rates. J Cell Biol 129:1311-1328. 
11. Vitre, B., F. M. Coquelle, C. Heichette, C. Garnier, D. Chretien, and I. 
Arnal. 2008. EB1 regulates microtubule dynamics and tubulin sheet 
closure in vitro. Nat Cell Biol 10:415-421. 
12. Hoog, J. L., S. M. Huisman, Z. Sebo-Lemke, L. Sandblad, J. R. 
McIntosh, C. Antony, and D. Brunner. 2011. Electron tomography 
reveals a flared morphology on growing microtubule ends. J Cell Sci 
124:693-698. 
13. Andreu, J. M., J. Bordas, J. F. Díaz, J. Garcia de Ancos, R. Gil, F. J. 
Medrano, E. Nogales, E. Pantos, and E. Towns-Andrews. 1992. Low 
resolution structure of microtubules in solution. Synchrotron X-ray 
scattering and electron microscopy of taxol-induced microtubules 
assembled from purified tubulin in comparison with glycerol and MAP-
induced microtubules. J Mol Biol 226:169-184. 
14. Andreu, J. M., J. F. Díaz, R. Gil, J. M. de Pereda, M. Garcia de Lacoba, 
V. Peyrot, C. Briand, E. Towns-Andrews, and J. Bordas. 1994. Solution 
structure of Taxotere-induced microtubules to 3-nm resolution. The 
change in protofilament number is linked to the binding of the taxol side 
 15 
 
chain. J Biol Chem 269:31785-31792. 
15. Díaz, J. F., J. M. Valpuesta, P. Chacón, G. Diakun, and J. M. Andreu. 
1998. Changes in microtubule protofilament number induced by Taxol 
binding to an easily accessible site. Internal microtubule dynamics. J 
Biol Chem 273:33803-33810. 
16. Díaz, J. F., R. Strobe, Y. Engelborghs, A. A. Souto, and J. M. Andreu. 
2000. Molecular recognition of taxol by microtubules. Kinetics and 
thermodynamics of binding of fluorescent taxol derivatives to an 
exposed site. J Biol Chem 275:26265-26276. 
17. Nogales, E., M. Whittaker, R. A. Milligan, and K. H. Downing. 1999. 
High-resolution model of the microtubule. Cell 96:79-88. 
18. Díaz, J. F., I. Barasoain, A. A. Souto, F. Amat-Guerri, and J. M. 
Andreu. 2005. Macromolecular accessibility of fluorescent taxoids 
bound at a paclitaxel binding site in the microtubule surface. J Biol 
Chem 280:3928-3937. 
19. Buey, R. M., E. Calvo, I. Barasoain, O. Pineda, M. C. Edler, R. 
Matesanz, G. Cerezo, C. D. Vanderwal, B. W. Day, E. J. Sorensen, J. 
A. Lopez, J. M. Andreu, E. Hamel, and J. F. Díaz. 2007. Cyclostreptin 
binds covalently to microtubule pores and lumenal taxoid binding sites. 
Nature Chem Biol 3:117-125. 
20. Barasoain, I., A. M. Garcia-Carril, R. Matesanz, G. Maccari, M. Trigili, 
M. Mori, J. Z. Shi, W. S. Fang, J. M. Andreu, M. Botta, and J. F. Díaz. 
2010. Probing the pore drug binding site of microtubules with 
fluorescent taxanes: Evidence of two binding poses. Chem Biol 17:243-
253. 
21. Canales, A., J. R. Salarichs, C. Trigili, L. Nieto, C. Coderch, J. M. 
Andreu, I. Paterson, J. Jiménez-Barbero, and J. F. Díaz. 2011. Insights 
into the interaction of discodermolide and docetaxel with dimeric 
tubulin.  Mapping the binding sites of microtubule-stabilizing agents 
using an integrated NMR and computational approach. ACS Chemical 
Biology 6:789-799. 
22. Amos, L. A., and J. Lowe. 1999. How Taxol stabilises microtubule 
structure. Chem Biol 6:R65-69. 
23. Matesanz, R., I. Barasoain, C. Yang, L. Wang, X. Li, C. De Ines, C. 
Coderch, F. Gago, J. Jiménez-Barbero, J. M. Andreu, W. Fang, and D. 
JF. 2008. Optimization of taxane binding to microtubules. Binding 
affinity decomposition and incremental construction of a high-affinity 
analogue of paclitaxel. Chem Biol 15:573-585. 
24. Souto, A. A., A. U. Acuña, J. M. Andreu, I. Barasoain, M. Abal, and F. 
AmatGuerri. 1995. New fluorescent water-soluble taxol derivatives. 
Angew Chem Int Ed Engl 34:2710-2712. 
25. Andreu, J. M., M. J. Gorbunoff, J. C. Lee, and S. N. Timasheff. 1984. 
Interaction of tubulin with bifunctional colchicine analogues: an 
equilibrium study. Biochemistry 23:1742-1752. 
26. Abramowitz, M., and I. A. Stegun. 1965. Handbook of Mathematical 
Functions. Dover Publications Inc., New York. 
27. Case, D. A., T. E. Cheatham, T. Darden, H. Gohlke, R. Luo, K. M. 
Merz, A. Onufriev, C. Simmerling, B. Wang, and R. J. Woods. 2005. 
The Amber biomolecular simulation programs. J. Comput. Chem. 
26:1668-1688. 
 16 
 
28. Sanner, M. F., A. J. Olson, and J. C. Spehner. 1996. Reduced surface: 
an efficient way to compute molecular surfaces. Biopolymers 38:305-
320. 
29. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. 
Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera--a 
visualization system for exploratory research and analysis. J Comput 
Chem 25:1605-1612. 
30. Jayalakshmi, V., and N. R. Krishna. 2002. Complete relaxation and 
conformational exchange matrix (CORCEMA) analysis of 
intermolecular saturation transfer effects in reversibly forming ligand-
receptor complexes. J Magn Reson 155:106-118. 
31. Snyder, J. P., J. H. Nettles, B. Cornett, K. H. Downing, and E. Nogales. 
2001. The binding conformation of Taxol in beta-tubulin: A model 
based on electron crystallographic density. Proc Natl Acad Sci U S A 
98:5312-5316. 
32. Magnani, M., G. Maccari, J. M. Andreu, J. F. Diaz, and M. Botta. 2009. 
Possible binding site for paclitaxel at microtubule pores. FEBS J 
276:2701-2712. 
33. Freedman, H., J. T. Huzil, T. Luchko, R. F. Luduena, and J. A. 
Tuszynski. 2009. Identification and characterization of an intermediate 
taxol binding site within microtubule nanopores and a mechanism for 
tubulin isotype binding selectivity. J Chem Inf Model 49:424-436. 
34. Canales, A., R. Matesanz, N. M. Gardner, J. M. Andreu, I. Paterson, J. 
F. Diaz, and J. Jimenez-Barbero. 2008. The Bound Conformation of 
Microtubule-Stabilizing Agents: NMR Insights into the Bioactive 3D 
Structure of Discodermolide and Dictyostatin. Chemistry Eur. J. 
14:7557-7569. 
35. Díaz, J. F., I. Barasoain, and J. M. Andreu. 2003. Fast kinetics of Taxol 
binding to microtubules. Effects of solution variables and microtubule-
associated proteins. J Biol Chem 278:8407-8419. 
36. Mitra, A., and D. Sept. 2008. Taxol Allosterically Alters the Dynamics of 
the Tubulin Dimer and Increases the Flexibility of Microtubules. 
Biophysical Journal 95:3252-3258. 
37. Alcaraz, A. A., A. K. Mehta, S. A. Johnson, and J. P. Snyder. 2006. T-
taxol conformation. J Med Chem 49:2478-2488. 
 
  
 17 
 
Table I: Structural data of the ligand induced microtubules 
Compound J01 (nm-1)a Mean helical 
radius (nm)b 
Average 
protofilament 
numberc 
Baccatin III 0.0595±0.0006 10.3±0.2 11.3±0.3 
Cephalomannine 0.0535±0.0002 11.4±0.1 12.6±0.1 
Paclitaxel 0.0518±0.0004 11.8±0.1 13.0±0.1 
Docetaxel 0.0480±0.0005 12.7±0.2 14.0±0.2 
Chitax-1 0.0455±0.0002 13.4±0.1 14.8±0.1 
Chitax-4 0.0443±0.0008 13.8±0.3 15.2±0.3 
Chitax-5 0.0435±0.0005 14.0±0.1 15.5±0.1 
Chitax-11 0.0498±0.0003 12.2±0.1 13.5±0.1 
Chitax-12 0.0501±0.0003 12.2±0.1 13.4±0.1 
Chitax-13 0.0518±0.0004 11.8±0.1 13.0±0.1 
Chitax-14 0.0493±0.0002 12.4±0.1 13.6±0.1 
Chitax-15 0.0504±0.0003 12.1±0.1 13.3±0.1 
Chitax-17 0.0501±0.0003 12.2±0.1 13.4±0.1 
Chitax-18 0.0543±0.0004 11.2±0.1 12.4±0.1 
Chitax-19 0.0476±0.0003 12.8±0.1 14.1±0.1 
Chitax-20 0.0503±0.0004 12.1±0.1 13.4±0.1 
Chitax-21 0.0513±0.0006 11.9±0.2 13.1±0.3 
Chitax-40 0.0521±0.0005 11.7±0.2 12.9±0.2 
Flutax-1 0.0460±0.0002 13.3±0.1 14.6±0.1 
Flutax-2 0.0460±0.0002 13.3±0.1 14.6±0.1 
Hexaflutax 0.0446±0.0003 13.7±0.1 15.1±0.1 
 
aJ01: position of the J01 maxima in the scattering profiles obtained from three 
independent measurements. Fitting of the peaks was done using the curve-
fitting software tool TableCurve2D 5.01 (Systat Software Inc. Richmond, Ca). 
The error is the error of the best fit. 
bRadii is the helical radii estimated from the positions of the first subsidiary 
maximum of the J0 Bessel function J01=(1.22/2R) (26). 
cCalculated from the mean helical radius and the microtubule 
interprotofilament spacing (5.7 nm) (14). 
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Table II: Changes in protofilament numbers due to single point modifications. 
Modification 
type Modification Compounds 
Change in pf
number 
Average 
changea 
V-SES (Å3)b 
C2 Benzoyl to 3-N3 benzoyl P->12 +0.4 +0.7±0.2 +35 
  C->14 +1.0   
  18->20 +1.0   
  1->4 +0.4   
 Benzoyl to 3-OCH3 benzoyl P->11 +0.5 +0.8±0.3 +24 
  C->13 +0.4   
  18->19 +1.7   
  1->5 +0.7   
C7 -OH to propionyl 17->1 +1.4 +1.4 +52 
 -OH to Fluorescein P->Flutax-1 +1.6 +1.6 +366 
 -OH to diFluoro-Fluorescein P->Flutax-2 +1.6 +1.6 +375 
 -OH to (CH2)6-Fluorescein P->Hexaflutax +2.1 +2.1 +453 
C10 -OH to Acetyl 17->C -0.8 -0.7±0.2 +48 
  15->P -0.3   
  D->21 -0.9   
 -OH to Propionyl 17->18 -1.0 -1.0 +53 
C13 PTX->CPH P->C -0.4 -0.2±0.2 -15 
  11->13 -0.5   
  12->14 +0.2   
  15->17 +0.1   
 PTX->DXL P->21 +0.1 +0.1 +11 
 CPH->DXL C->21 +0.5 +0.2±0.3 +8 
  17->D +0.6   
  20->40 -0.5   
 PTX->None P-> BIII -1.7 -1.7 -256 
 
a Errors are the standard error where applicable 
b V-SES Volume of Solvent Excluded Surface  
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Figure legends. 
Figure 1: Upper panel: Structural pathway of MSA-induced microtubule 
assembly, adapted from (8). Lower panel: Chemical structures of the 
compounds employed in the study. 
Figure 2: Effect of single modifications in the different side chains on the 
SAXS profiles of microtubules assembled in the presence of different 
taxanes. A. Effect of changes in C13 side chain. SAXS profiles of 
microtubules assembled in the presence of Chitax-21 (black line), 
Cephalomannine (red line) or paclitaxel (green line) Inset: Schematic drawing 
of a microtubule indicating the interprotofilament angle. B. Effect of changes in 
C10 side chain. SAXS profiles of microtubules assembled in the presence of 
Chitax-18 (black line), Cephalomannine (red line) or Chitax-17 (green line) C. 
Effect of changes in C7 side chain. SAXS profiles of microtubules assembled 
in the presence of Chitax-1 (black line), Cephalomannine (red line) or Chitax-
17 (green line). D. Effect of changes in C2 side chain. SAXS profiles of 
microtubules assembled in the presence of Chitax-13 (black line), 
Cephalomannine (red line) or Chitax-14 (green line). 
Figure 3.- NMR directed modeling of the ligands bound to the pore site. 
A.- Off-resonance NMR experiment (500 MHz) (lower line) and STD spectra 
(upper line) of Flutax-2 bound to microtubules, Inset: TR-NOESY spectra 
(mixing time: 200 ms) of Flutax-2 in the presence of microtubules (D2O, 310 
K) (a large high resolution version of this file is available as supplementary 
information). B.-Best model of Flutax-2 docked into the pore site. Protein 
residues considered in CORCEMA-ST calculations are shown in sticks. C.- 
Experimental STD profile of Flutax-2 bound to microtubules (black line and 
circles). Calculated STD profile of the best model of Flutax-2 docked into the 
pore site (red line and squares). D.- Average STD profile of the common 
protons of paclitaxel, docetaxel and Chitax-42 (black line and circles). 
Calculated STD profile of cephalomaninne docked into the pore site (red line 
and squares). Calculated STD profile of Chitax-1 docked into the pore site 
(green line and squares). Calculated STD profile of Chitax-17 docked into the 
pore site (blue line and squares). Calculated STD profile of Chitax-4 docked 
into the pore site (pink line and squares). X-axis values of Figures 3C and 3D 
are placed over the symbols and represent the common protons of taxane 
core and/or the fluorescein moiety of Flutax-2. The order of the points have 
been selected so points representing protons close in the graph are as well 
close in the taxane molecule (protons not observable by STD keep its space 
but are not plotted), spacing and connectivity of the points are arbitrary for 
presentation purposes.  
Figure 4.- Models of ligands bound to microtubules Panels A-C Ligands 
bound to pore site: (A) Cephalomannine, (B) Chitax-1, (C) Flutax-2, (Magenta, 
H3 Helix of -tubulin subunit, White, S3 of 3-tubulin subunit) Panel D 
Scheme of the interaction of ligand at both binding sites with the structural 
elements responsible for the interprotofilament interaction. The scheme 
shows the position of H3, S3 and the M-loop in the interprotofilament interface 
with respect with the two possible binding sites for the taxanes, and the 
substituents of the ligand that interact with them altering the interprotofilament 
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contacts. A ligand bound to the pore site will interact with H3 through the 
substituent at position C7, increasing the interprotofilament angle and with S3 
through the substituent at position C10 decreasing the angle. A ligand bound 
to the luminal site will interact with the M-loop through the substituent at 
position C10 producing the same effect as in the pore site. Microtubule is 
seen from the plus end. Panels E-H ligands bound to luminal site (E) 
Cephalomannine. (F) Chitax-1. (G) Chitax-4. (H) Chitax-17. Magenta H3 Helix 
of 3-tubulin subunit, White S3 of 3-tubulin subunit. Yellow M-loop of 1-
tubulin subunit.  
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